. . "The invention contemplates that the use of human antibodies, ???humanized??? or chimeric antibodies from mouse, rat, or other species, bearing human constant and/or variable region domains, single domain antibodies (e.g., DABs), Fv domains, as well as recombinant antibodies and fragments thereof. of course, due to the ease of preparation and ready availability of reagents, murine monoclonal antibo" . . .